STOCK TITAN
  1. Home
  2. Sec-filings
  3. ROIV
  4. [144] Roivant Sciences Ltd. SEC Filing

Roivant Sciences (ROIV) affiliate files to sell 200,000 common shares after option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Roivant Sciences Ltd. received a notice that affiliate Eric Venker plans to sell 200,000 common shares, expected to be issued from an option exercise granted on 04/20/2022, with a proposed sale date of 07/27/2026 on NASDAQ via wire settlement.

The notice also lists sales during the prior three months: 200,000 common shares on 05/22/2026 for an aggregate value of 6,054,730.92 and another 200,000 common shares on 06/24/2026 for an aggregate value of 6,631,659.08, each by Eric Venker.

Positive

  • None.

Negative

  • None.
Proposed shares to be sold 200,000 shares Common shares proposed for sale with expected sale date 07/27/2026
Aggregate value of proposed sale 6,989,924.05 Reported value associated with 200,000 common shares to be sold
Shares sold 05/22/2026 200,000 shares Common shares sold by Eric Venker on 05/22/2026
Aggregate value on 05/22/2026 6,054,730.92 Reported aggregate value for 200,000 shares sold on 05/22/2026
Shares sold 06/24/2026 200,000 shares Common shares sold by Eric Venker on 06/24/2026
Aggregate value on 06/24/2026 6,631,659.08 Reported aggregate value for 200,000 shares sold on 06/24/2026
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Options Exercise financial
"Options Exercise - Grant Date 04/20/2022"
Exercising an option is the act of using a contract that gives you the right to buy or sell a specific stock at a set price. For investors, the decision to exercise matters because it turns a paper right into an actual trade — it can create immediate profit or loss, change how many shares are outstanding (which can dilute ownership), affect cash the investor must pay or receive, and trigger tax consequences, much like deciding to redeem a coupon for a fixed-price purchase.
Common Shares financial
"Common Shares | 07/27/2026 | Options Exercise"
Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.
Securities Sold During The Past 3 Months regulatory
"144: Securities Sold During The Past 3 Months"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does Roivant Sciences (ROIV) report in this Form 144 notice?
Roivant Sciences is reported as the issuer for a planned sale of 200,000 common shares by affiliate Eric Venker, expected to be issued from an option exercise granted on 04/20/2022 and proposed to be sold on 07/27/2026 on NASDAQ.

How many Roivant Sciences (ROIV) shares are proposed to be sold?
The filing reports a proposed sale of 200,000 common shares of Roivant Sciences. These shares are tied to an options exercise with a grant date of 04/20/2022, with a proposed sale date of 07/27/2026 on NASDAQ.

What prior Roivant Sciences (ROIV) share sales are disclosed for the last 3 months?
The notice lists two past sales by Eric Venker: 200,000 common shares on 05/22/2026 for 6,054,730.92 and 200,000 common shares on 06/24/2026 for 6,631,659.08, both involving Roivant Sciences common shares.

Who is the selling security holder in the Roivant Sciences (ROIV) Form 144?
The selling security holder is identified as Eric Venker, care of Roivant Sciences Ltd., 7th Floor, 50 Broadway, London. He is associated with both the proposed 200,000-share sale and the two prior 200,000-share sales disclosed.

What is the role of options in the planned Roivant Sciences (ROIV) share sale?
The planned sale of 200,000 common shares is linked to an “Options Exercise – Grant Date 04/20/2022”. This indicates the seller expects to receive the shares through exercising options granted on that date before selling them.

On which market is the planned Roivant Sciences (ROIV) sale expected to occur?
The proposed sale of 200,000 Roivant Sciences common shares is associated with trading on NASDAQ. Settlement is indicated as by wire, and the proposed date for the transaction is 07/27/2026.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR